{
  "schema_version": "0.1.0",
  "id": "fda-drug-shortage:lisdexamfetamine-dimesylate-tablet-chewable",
  "slug": "lisdexamfetamine-dimesylate-tablet-chewable",
  "title": "FDA shortage status: Lisdexamfetamine Dimesylate Tablet, Chewable",
  "ingredient": "Lisdexamfetamine Dimesylate Tablet, Chewable",
  "status": "current",
  "source_statuses": [
    "Current"
  ],
  "brand_names": [
    "LISDEXAMFETAMINE DIMESYLATE",
    "VYVANSE"
  ],
  "therapeutic_categories": [
    "Psychiatry"
  ],
  "dosage_forms": [
    "Tablet, Chewable"
  ],
  "routes": [
    "ORAL"
  ],
  "package_count": 18,
  "packages": [
    {
      "package_ndc": "72205-132-91",
      "product_ndc": "72205-132",
      "company_name": "Novadoz Pharmaceuticals LLC",
      "manufacturer_name": "Novadoz Pharmaceuticals LLC",
      "presentation": "Lisdexamfetamine Dimesylate, Tablet, Chewable, 10 mg (NDC 72205-132-91)",
      "availability": "Available",
      "dosage_form": "Tablet, Chewable",
      "routes": [
        "ORAL"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "07/14/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "72205-133-91",
      "product_ndc": "72205-132",
      "company_name": "Novadoz Pharmaceuticals LLC",
      "manufacturer_name": "Novadoz Pharmaceuticals LLC",
      "presentation": "Lisdexamfetamine Dimesylate, Tablet, Chewable, 20 mg (NDC 72205-133-91)",
      "availability": "Available",
      "dosage_form": "Tablet, Chewable",
      "routes": [
        "ORAL"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "07/14/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "72205-134-91",
      "product_ndc": "72205-132",
      "company_name": "Novadoz Pharmaceuticals LLC",
      "manufacturer_name": "Novadoz Pharmaceuticals LLC",
      "presentation": "Lisdexamfetamine Dimesylate, Tablet, Chewable, 30 mg (NDC 72205-134-91)",
      "availability": "Available",
      "dosage_form": "Tablet, Chewable",
      "routes": [
        "ORAL"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "07/14/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "72205-135-91",
      "product_ndc": "72205-132",
      "company_name": "Novadoz Pharmaceuticals LLC",
      "manufacturer_name": "Novadoz Pharmaceuticals LLC",
      "presentation": "Lisdexamfetamine Dimesylate, Tablet, Chewable, 40 mg (NDC 72205-135-91)",
      "availability": "Available",
      "dosage_form": "Tablet, Chewable",
      "routes": [
        "ORAL"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "07/14/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "72205-136-91",
      "product_ndc": "72205-132",
      "company_name": "Novadoz Pharmaceuticals LLC",
      "manufacturer_name": "Novadoz Pharmaceuticals LLC",
      "presentation": "Lisdexamfetamine Dimesylate, Tablet, Chewable, 50 mg (NDC 72205-136-91)",
      "availability": "Available",
      "dosage_form": "Tablet, Chewable",
      "routes": [
        "ORAL"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "07/14/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "72205-137-91",
      "product_ndc": "72205-132",
      "company_name": "Novadoz Pharmaceuticals LLC",
      "manufacturer_name": "Novadoz Pharmaceuticals LLC",
      "presentation": "Lisdexamfetamine Dimesylate, Tablet, Chewable, 60 mg (NDC 72205-137-91)",
      "availability": "Available",
      "dosage_form": "Tablet, Chewable",
      "routes": [
        "ORAL"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "07/14/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "57664-083-88",
      "product_ndc": "57664-046",
      "company_name": "Sun Pharmaceutical Industries, Inc.",
      "manufacturer_name": "Sun Pharmaceutical Industries, Inc.",
      "presentation": "Lisdexamfetamine Dimesylate, Tablet, Chewable, 10 mg (NDC 57664-083-88)",
      "availability": "Available",
      "dosage_form": "Tablet, Chewable",
      "routes": [
        "ORAL"
      ],
      "update_date": "08/05/2026",
      "initial_posting_date": "07/14/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "57664-084-88",
      "product_ndc": "57664-046",
      "company_name": "Sun Pharmaceutical Industries, Inc.",
      "manufacturer_name": "Sun Pharmaceutical Industries, Inc.",
      "presentation": "Lisdexamfetamine Dimesylate, Tablet, Chewable, 20 mg (NDC 57664-084-88)",
      "availability": "Available",
      "dosage_form": "Tablet, Chewable",
      "routes": [
        "ORAL"
      ],
      "update_date": "08/05/2026",
      "initial_posting_date": "07/14/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "57664-085-88",
      "product_ndc": "57664-046",
      "company_name": "Sun Pharmaceutical Industries, Inc.",
      "manufacturer_name": "Sun Pharmaceutical Industries, Inc.",
      "presentation": "Lisdexamfetamine Dimesylate, Tablet, Chewable, 30 mg (NDC 57664-085-88)",
      "availability": "Available",
      "dosage_form": "Tablet, Chewable",
      "routes": [
        "ORAL"
      ],
      "update_date": "08/05/2026",
      "initial_posting_date": "07/14/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "57664-086-88",
      "product_ndc": "57664-046",
      "company_name": "Sun Pharmaceutical Industries, Inc.",
      "manufacturer_name": "Sun Pharmaceutical Industries, Inc.",
      "presentation": "Lisdexamfetamine Dimesylate, Tablet, Chewable, 40 mg (NDC 57664-086-88)",
      "availability": "Available",
      "dosage_form": "Tablet, Chewable",
      "routes": [
        "ORAL"
      ],
      "update_date": "08/05/2026",
      "initial_posting_date": "07/14/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "57664-087-88",
      "product_ndc": "57664-046",
      "company_name": "Sun Pharmaceutical Industries, Inc.",
      "manufacturer_name": "Sun Pharmaceutical Industries, Inc.",
      "presentation": "Lisdexamfetamine Dimesylate, Tablet, Chewable, 50 mg (NDC 57664-087-88)",
      "availability": "Available",
      "dosage_form": "Tablet, Chewable",
      "routes": [
        "ORAL"
      ],
      "update_date": "08/05/2026",
      "initial_posting_date": "07/14/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "57664-088-88",
      "product_ndc": "57664-046",
      "company_name": "Sun Pharmaceutical Industries, Inc.",
      "manufacturer_name": "Sun Pharmaceutical Industries, Inc.",
      "presentation": "Lisdexamfetamine Dimesylate, Tablet, Chewable, 60 mg (NDC 57664-088-88)",
      "availability": "Available",
      "dosage_form": "Tablet, Chewable",
      "routes": [
        "ORAL"
      ],
      "update_date": "08/05/2026",
      "initial_posting_date": "07/14/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "59417-115-01",
      "product_ndc": "59417-101",
      "company_name": "Takeda Pharmaceuticals USA Inc.",
      "manufacturer_name": "Takeda Pharmaceuticals America, Inc.",
      "presentation": "Vyvanse, Tablet, Chewable, 10 mg (NDC 59417-115-01)",
      "availability": "Available",
      "dosage_form": "Tablet, Chewable",
      "routes": [
        "ORAL"
      ],
      "update_date": "06/23/2026",
      "initial_posting_date": "07/14/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "59417-116-01",
      "product_ndc": "59417-101",
      "company_name": "Takeda Pharmaceuticals USA Inc.",
      "manufacturer_name": "Takeda Pharmaceuticals America, Inc.",
      "presentation": "Vyvanse, Tablet, Chewable, 20 mg (NDC 59417-116-01)",
      "availability": "Available",
      "dosage_form": "Tablet, Chewable",
      "routes": [
        "ORAL"
      ],
      "update_date": "06/23/2026",
      "initial_posting_date": "07/14/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "59417-117-01",
      "product_ndc": "59417-101",
      "company_name": "Takeda Pharmaceuticals USA Inc.",
      "manufacturer_name": "Takeda Pharmaceuticals America, Inc.",
      "presentation": "Vyvanse, Tablet, Chewable, 30 mg (NDC 59417-117-01)",
      "availability": "Available",
      "dosage_form": "Tablet, Chewable",
      "routes": [
        "ORAL"
      ],
      "update_date": "06/23/2026",
      "initial_posting_date": "07/14/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "59417-118-01",
      "product_ndc": "59417-101",
      "company_name": "Takeda Pharmaceuticals USA Inc.",
      "manufacturer_name": "Takeda Pharmaceuticals America, Inc.",
      "presentation": "Vyvanse, Tablet, Chewable, 40 mg (NDC 59417-118-01)",
      "availability": "Available",
      "dosage_form": "Tablet, Chewable",
      "routes": [
        "ORAL"
      ],
      "update_date": "06/23/2026",
      "initial_posting_date": "07/14/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "59417-119-01",
      "product_ndc": "59417-101",
      "company_name": "Takeda Pharmaceuticals USA Inc.",
      "manufacturer_name": "Takeda Pharmaceuticals America, Inc.",
      "presentation": "Vyvanse, Tablet, Chewable, 50 mg (NDC 59417-119-01)",
      "availability": "Available",
      "dosage_form": "Tablet, Chewable",
      "routes": [
        "ORAL"
      ],
      "update_date": "06/23/2026",
      "initial_posting_date": "07/14/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "59417-120-01",
      "product_ndc": "59417-101",
      "company_name": "Takeda Pharmaceuticals USA Inc.",
      "manufacturer_name": "Takeda Pharmaceuticals America, Inc.",
      "presentation": "Vyvanse, Tablet, Chewable, 60 mg (NDC 59417-120-01)",
      "availability": "Available",
      "dosage_form": "Tablet, Chewable",
      "routes": [
        "ORAL"
      ],
      "update_date": "06/23/2026",
      "initial_posting_date": "07/14/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    }
  ],
  "availability_counts": {
    "Available": 18
  },
  "initial_posting_date": "07/14/2023",
  "latest_source_update": "08/17/2026",
  "source_updated_at": "2026-08-22",
  "official_url": "https://api.fda.gov/drug/shortages.json",
  "source_name": "U.S. Food and Drug Administration openFDA Drug Shortages",
  "source_license_url": "https://open.fda.gov/license/",
  "retrieved_at": "2026-08-22T15:54:11+00:00",
  "unknowns": {
    "local_availability": "Unknown. FDA status is nationwide and is not local inventory.",
    "clinical_alternatives": "Not provided. CiteFacts does not publish treatment or substitution advice.",
    "resolution_date": "Unknown unless an FDA source row provides an update date."
  },
  "derivations": {
    "status": "current when a grouped FDA row has Current; otherwise it preserves the available FDA Resolved, Discontinuation, or not-current state.",
    "ingredient_page": "Grouped by FDA generic_name, falling back to openFDA.generic_name.",
    "availability_counts": "Count of non-empty FDA package availability values; it is not a claim about local supply."
  }
}